BioPharm International
March 01, 2008
Columns and Departments
21
3
The supply base for preclinical and clinical development services continues to expand in China.
March 01, 2008
Features
21
3
Two business models that companies can follow to map their strategy from concept to implementation.
March 01, 2008
Columns and Departments
21
3
India is restructuring its regulation of biopharmaceuticals to help the country's industry compete internationally.
March 01, 2008
Columns and Departments
21
3
More informed submissions may lead to regulatory flexibility for postapproval changes.
March 01, 2008
Columns and Departments
21
3
Despite the rising fears about a slowing economy, the biotech industry will continue to maintain its momentum this year.
March 01, 2008
Columns and Departments
21
3
A comprehensive process and analytical transfer package can speed up your product's time to market and save costs.
March 01, 2008
Columns and Departments
21
3
How an electronics engineer led the first Indian company to carry out indigenous development of a recombinant vaccine.
March 01, 2008
Features
21
3
Emerging therapies pose challenges for standardizing QC.
March 01, 2008
Columns and Departments
21
3
The expanding globalization of the industry poses a challenge for international enforcement.
March 01, 2008
Columns and Departments
21
3
The cause of the heparin crisis is still unknown. We do know, however, that the FDA is severely underfunded.
March 01, 2008
Features
21
3
Need a standard to follow? Just ask, What would Genentech do?